Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China.
about
ImmunoChip study implicates antigen presentation to T cells in narcolepsyA practical guide to the therapy of narcolepsy and hypersomnia syndromesShining evolutionary light on human sleep and sleep disordersVaccination of healthcare workers: A reviewUnmet needs of patients with narcolepsy: perspectives on emerging treatment optionsFluad®-MF59®-Adjuvanted Influenza Vaccine in Older AdultsSafety assessment of adjuvanted vaccines: Methodological considerationsH1N1 influenza virus induces narcolepsy-like sleep disruption and targets sleep-wake regulatory neurons in mice.AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in FinlandGenome wide analysis of narcolepsy in China implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemicHeterologous prime-boost vaccination using an AS03B-adjuvanted influenza A(H5N1) vaccine in infants and children<3 years of age.Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France.An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants.No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland.Narcolepsy and A(H1N1)pdm09 vaccination: shaping the research on the observed signal.Narcolepsy as an immune-mediated diseaseHistory of narcolepsy at Stanford University.Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England.Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec.AS03B-adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo-controlled, observer-blinded trial.Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk.HLA-DPB1 and HLA class I confer risk of and protection from narcolepsyPhase II, randomized, open, controlled study of AS03-adjuvanted H5N1 pre-pandemic influenza vaccine in children aged 3 to 9 years: follow-up of safety and immunogenicity persistence at 24 months post-vaccination.Increased β-haemolytic group A streptococcal M6 serotype and streptodornase B-specific cellular immune responses in Swedish narcolepsy cases.Incidence of Narcolepsy in GermanyA coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009-2010 Pandemrix vaccination programme in Sweden.Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2.Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, children and adolescents: Two open, uncontrolled studiesPandemrix™ and narcolepsy: A critical appraisal of the observational studies.Application of Probabilistic Multiple-Bias Analyses to a Cohort- and a Case-Control Study on the Association between Pandemrix™ and Narcolepsy.Twin Peaks: A/H1N1 Pandemic Influenza Virus Infection and Vaccination in Norway, 2009-2010.Evaluation of the potential effects of AS03-adjuvanted A(H1N1)pdm09 vaccine administration on the central nervous system of non-primed and A(H1N1)pdm09-primed cotton ratsSleep: narcolepsy associated with the 2009 H1N1 pandemic in China.Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion.Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland.Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic.The autoimmune basis of narcolepsySleep physiology, abnormal States, and therapeutic interventions.Clinical and polysomnographic course of childhood narcolepsy with cataplexy.Key sleep neurologic disorders: Narcolepsy, restless legs syndrome/Willis-Ekbom disease, and REM sleep behavior disorder.
P2860
Q23936601-66066C23-3CBF-414E-8F66-61756268FF25Q24623713-BA09C69E-1593-4AE0-A4A0-EC3DC2DB7A50Q26741060-80911A2E-5331-4D04-9C93-07E198D38673Q26796300-7780E79A-C3E5-4AC0-8C64-24AAD0C523CEQ26827736-132CC7D7-80B0-44AC-AE32-45DDA52F697AQ27009478-E8CA6AC4-BA65-4A3A-8C8E-CC913C8F5E55Q27013956-6D9DCD6C-9926-4A2E-B4B3-F5E3D75AB680Q27317087-C2AF8F0A-8BB1-4DBF-92F7-D6390D34B892Q28730881-65B89BB7-10F2-4FBC-B734-0F47FAB780CAQ28943299-225F5DBD-D53D-40C5-A0F1-F5D54462D718Q30209583-B03507CC-5F36-49D6-8DAC-B130E96DEF6FQ30352315-448A9B80-DC69-4C79-8BCE-7E3A3BDC0A00Q30352329-115A9293-02FA-4649-BEFF-29723C61BF12Q30352889-3E7430B2-2B8D-42A5-A50E-0DDCD5D07C28Q30356910-47AABEEE-5F07-4C8B-B0C1-710BE02E2E12Q30359247-E6D86D9C-9599-4A23-86E4-B9A7134A6C8FQ30362536-5EA26A84-8F19-4290-9F9F-C5E43BC4DC69Q30364889-ECE62943-6AFA-4844-9ABD-A1231D1AD4C6Q30367259-527FEAC9-A642-4C23-9F3E-35522301E26CQ30367603-E6056F3D-A9C7-40C7-B5C3-1D4D206A38F6Q30369654-D87A9B84-A497-48D5-8EEE-E26604013737Q30370632-3FB1481A-5D73-467D-9408-7ED301E01AEBQ30371445-C942F603-E7B7-4BA3-9D3F-50167CCAE2A1Q30371742-C7DAEE18-BB2B-4BF9-B6C7-79332563F0ECQ30374045-AA0C22AD-C88C-4621-9F68-2B5EFE3DD3FEQ30376157-0C643906-169D-459F-A010-36FD4E373727Q30376254-468D5311-4940-461B-BB42-A3B924EA4B4EQ30376727-B114BBA6-2D77-4D7A-85A8-866922C845B9Q30379224-EC7DF9CE-C636-42C7-BDDE-5925CD84ACDAQ30384711-7E6C8FE1-286F-4745-86CA-67D0C19920A8Q30386044-6FA27DD2-53D5-46F5-8058-3FA48A2B92F8Q30392931-D6E3B2CC-571F-4FB7-B170-565DA913A2D3Q30407972-F7F9AF76-0AE9-4AAB-A2ED-F1DD45B348B3Q30413695-56D9EFB8-BFFD-40B5-A9D8-DB1D0C65A2C7Q30414919-7562008B-CB00-4F5C-AFA2-17DA126F7BE8Q30424553-EFD4EE63-BD6F-4250-99F1-A901229B9983Q30431335-D2098667-69CB-4084-BFFC-3ADB076C9516Q30465865-55404D57-66AB-4C97-84C0-1DEFEB4E3643Q30559262-352B4E50-131E-4AE2-A500-418A920BFEF4Q30573489-4410B823-8A7F-4DFC-887D-CAA92196F6BE
P2860
Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China.
@ast
Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China.
@en
type
label
Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China.
@ast
Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China.
@en
prefLabel
Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China.
@ast
Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China.
@en
P2093
P2860
P356
P1433
P1476
Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China.
@en
P2093
Kingman P Strohl
Ling H Wang
Simon C Warby
P2860
P304
P356
10.1002/ANA.22587
P577
2011-08-22T00:00:00Z